A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.

We observe that only 0.8% of patients show mutations in the MARK4 gene ( Figure 5E ), while in terms of its clinical relevance, it appears highly significant where the p-value was 5.914e-3 ( Figure 7C ).

also in 132,142 other papers